Literature DB >> 2468570

The inhibition of neurite outgrowth in PC12 cells by tubulin antisense oligodeoxyribonucleotides.

A Teichman-Weinberg1, U Z Littauer, I Ginzburg.   

Abstract

A model system was designed to determine the effect of antisense oligodeoxyribonucleotides (oligos) on the expression of endogenous tubulin genes, the major component of microtubules, and to study the involvement of individual tubulin isoforms in specific functions, by employing antisense oligos which can block the expression of specific transcripts, both in vitro and in vivo. In reticulocyte cell-free system, specific inhibition of mRNA translation was observed with oligos complementary to the 5' alpha-tubulin-coding region. In vivo inhibition of neurite outgrowth was observed in nerve growth factor-induced PC12 cells. Specific inhibition was observed in cells treated with antisense oligos corresponding to the 5' alpha-tubulin-coding region as well as with antisense oligos corresponding to the 3' alpha-noncoding regions of two different alpha-tubulin isoforms. The results show that both tubulin isoforms are involved in neurite outgrowth and further demonstrate the ability of oligos to block expression of endogenous genes and thus follow the involvement of those gene products in cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2468570     DOI: 10.1016/0378-1119(88)90155-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Inhibition of gene expression by a short sense fragment.

Authors:  F H Cameron; P A Jennings
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

2.  Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices.

Authors:  R A Stull; L A Taylor; F C Szoka
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

3.  Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to beta-endorphin mRNA.

Authors:  S Spampinato; M Canossa; L Carboni; G Campana; G Leanza; S Ferri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

4.  Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.

Authors:  C Ramazeilles; R K Mishra; S Moreau; E Pascolo; J J Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

5.  Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake.

Authors:  C Chavany; T Saison-Behmoaras; T Le Doan; F Puisieux; P Couvreur; C Hélène
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

6.  Purification and characterization of human ribonuclease HII.

Authors:  P Frank; S Albert; C Cazenave; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

7.  The long repetitive polypurine/polypyrimidine sequence (TTCCC)48 forms DNA triplex with PU-PU-PY base triplets in vivo.

Authors:  D Michel; G Chatelain; Y Herault; G Brun
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

8.  Depletion of catalytic and regulatory subunits of protein kinase CK2 by antisense oligonucleotide treatment of neuroblastoma cells.

Authors:  L Ulloa; J Díaz-Nido; J Avila
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

9.  Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation.

Authors:  T Saison-Behmoaras; B Tocqué; I Rey; M Chassignol; N T Thuong; C Hélène
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

10.  Depletion of casein kinase II by antisense oligonucleotide prevents neuritogenesis in neuroblastoma cells.

Authors:  L Ulloa; J Díaz-Nido; J Avila
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.